Subscribe to Newsletter

Miguel Forte

Chief Executive Officer, Bone Therapeutics, and Professor, Lisbon University

Forte is the incoming president-elect of the International Society for Cell & Gene Therapy (from June 2022–2024). Forte holds an MD and Specialist in Infectious Diseases, a PhD in Immunology, and a certificate on Health Technologies Economics from the Stockholm School of Economics.

What is the biggest lesson the industry has learned during the COVID-19 pandemic?

The biggest lesson from the COVID-19 pandemic is the reactivity and ability of all of us to adapt and respond to a new and challenging situation. The biotech responded to the challenge and, together with regulators and other players, was able to deliver vaccine solutions in time. This went hand-in-hand with the regulators’ willingness to find pragmatic solutions for regulatory interactions and for the overall biotech business, from discussions to approvals. Finally we adapted to working remotely and business – from partnerships to fund raising – was able to progress. It was as if the old funding roadshows became “Zoomshows”!

If you weren’t in the pharma industry, what would you be doing?  

I would be producing wine in the Douro region, where port wine comes from, in line with the origins of my family!

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine